KRYS CapEx to Revenue

Krystal Biotech Inc · CapEx to Revenue

KRYS logo

KRYS CapEx to Revenue

Current (TTM)3.30%
KRYS CapEx/Revenue (0.00% → 3.30%)
High-resolution chart · PNG

KRYS capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
3.0712%
1.4588%
23.2726%
0%
0%
0%
0%
217.5268%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.